Companies: 48,874 Total Market Cap: 132391982605079.18

Laboratorios Richmond S.A.C.I.F.

BCBA-RICH

Healthcare Drug Manufacturers - Specialty & Generic

Rank #23628

Market Cap 105.64 M

Volume 9,030

Price 1.32

Change (%) 0.67%

Country or region

Argentina

Laboratorios Richmond S.A.C.I.F.'s latest marketcap:

105.64 M

As of 05/19/2025, Laboratorios Richmond S.A.C.I.F.'s market capitalization has reached $105.64 M. According to our data, Laboratorios Richmond S.A.C.I.F. is the 23628th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap	105.64 M
Revenue (ttm)	80.60 M
Net Income (ttm)	20.94 M
Shares Out	80.75 M
EPS (ttm)	0.26
Forward PE	0.00
Ex-Dividend Date	05/14/2025
Earnings Date	05/09/2025

Market Cap Chart

Data Updated: 05/19/2025

Laboratorios Richmond S.A.C.I.F.'s yearly market capitalization.

Laboratorios Richmond S.A.C.I.F. has seen its market value grow from ARS 9.33 B to ARS 120.32 B since 2020, representing a total increase of 1,190.04% and an annual compound growth rate (CAGR) of 79.16%.

Date	Market Cap	Change (%)
05/19/2025	ARS 120.32 B	-20.06%
12/30/2024	ARS 144.95 B	156.98%
12/29/2023	ARS 56.40 B	79.56%
12/30/2022	ARS 31.41 B	75.23%
12/30/2021	ARS 17.93 B	92.21%
12/30/2020	ARS 9.33 B

Company Profile

About Laboratorios Richmond S.A.C.I.F.

Laboratorios Richmond S.A.C.I.F. is a pharmaceutical company specializing in the development and manufacturing of a diverse range of medical products. Established in 1935 and headquartered in Buenos Aires, Argentina, the company serves markets across Latin America, Africa, Asia, and the Middle East.

Key Product Offerings

Antiretroviral Products: Treatments for human immunodeficiency virus (HIV).
Oncology & Oncohematology Drugs: Medications targeting cancer and blood-related disorders.
Cardiometabolic Drugs: Includes antihypertensives, hypocholesterolemics, platelet antiaggregants, and hypoglycemic medications.
Neurological & Psychiatric Drugs: Covers analgesics, antipsychotics, antidepressants, anti-dementia drugs, antiepileptics, hypnotics, and treatments for multiple sclerosis.

With decades of expertise, Laboratorios Richmond S.A.C.I.F. remains a trusted name in the global pharmaceutical industry.

Frequently Asked Questions

As of 05/19/2025, Laboratorios Richmond S.A.C.I.F. (including the parent company, if applicable) has an estimated market capitalization of $105.64 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Laboratorios Richmond S.A.C.I.F. global market capitalization ranking is approximately 23628 as of 05/19/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region	Argentina
Founded	1935
IPO Date	n/a
Employees	620
CEO	Juan Manuel Artola
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
Address	Bouchard 680 Buenos Aires Argentina
Website	https://www.richmondlab.com